Physician profile
Shellie Ann Rabner
NPI 1053065524
$5,665.46
in general payments reported to CMS, 2019-2025
40 companies · $1,734 in 2025
The $1,734 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $946 · 2023: $1,387 · 2024: $1,599 · 2025: $1,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,526 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,525.59 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $664.54 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Corium, LLC | $647.03 | 2023-2025 | Azstarys, Adlarity |
| Abbvie INC. | $471.54 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $459.78 | 2022-2025 | Rexulti |
| Pfizer INC. | $364.10 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $363.60 | 2022 | |
| Novo Nordisk INC | $338.63 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $288.88 | 2023-2025 | Veozah |
| Amgen INC. | $259.61 | 2022-2025 | Repatha, Evenity, Otezla |
| Verity Pharmaceuticals INC. | $224.32 | 2024-2025 | Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.17 | 2022-2025 | Xifaxan, Trulance |
| Axsome Therapeutics, INC. | $150.59 | 2024-2025 | Auvelity |
| Antares Pharma, INC. | $144.11 | 2022-2025 | Xyosted |
| Lundbeck LLC | $136.13 | 2022-2025 | Rexulti, Vyepti |
| Exact Sciences Corporation | $106.49 | 2023-2025 | Cologuard Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shellie Rabner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.